282 related articles for article (PubMed ID: 20233326)
1. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.
Liu CJ; Kao SY; Tu HF; Tsai MM; Chang KW; Lin SC
Oral Dis; 2010 May; 16(4):360-4. PubMed ID: 20233326
[TBL] [Abstract][Full Text] [Related]
2. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
4. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
5. Serum circulating human mRNA profiling and its utility for oral cancer detection.
Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT
J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414
[TBL] [Abstract][Full Text] [Related]
6. miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.
Yang CC; Hung PS; Wang PW; Liu CJ; Chu TH; Cheng HW; Lin SC
J Oral Pathol Med; 2011 May; 40(5):397-404. PubMed ID: 21244495
[TBL] [Abstract][Full Text] [Related]
7. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
Yang CJ; Shen WG; Liu CJ; Chen YW; Lu HH; Tsai MM; Lin SC
J Oral Pathol Med; 2011 Aug; 40(7):560-6. PubMed ID: 21226887
[TBL] [Abstract][Full Text] [Related]
8. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
Wong TS; Liu XB; Wong BY; Ng RW; Yuen AP; Wei WI
Clin Cancer Res; 2008 May; 14(9):2588-92. PubMed ID: 18451220
[TBL] [Abstract][Full Text] [Related]
9. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
10. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
[TBL] [Abstract][Full Text] [Related]
14. miRNA expression profiles of oral squamous cell carcinomas.
Gombos K; Horváth R; Szele E; Juhász K; Gocze K; Somlai K; Pajkos G; Ember I; Olasz L
Anticancer Res; 2013 Apr; 33(4):1511-7. PubMed ID: 23564792
[TBL] [Abstract][Full Text] [Related]
15. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
Hoffmann RR; Yurgel LS; Campos MM
Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma.
Ni YH; Huang XF; Wang ZY; Han W; Deng RZ; Mou YB; Ding L; Hou YY; Hu QG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):227-33. PubMed ID: 24439918
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.
Lu YC; Chen YJ; Wang HM; Tsai CY; Chen WH; Huang YC; Fan KH; Tsai CN; Huang SF; Kang CJ; Chang JT; Cheng AJ
Cancer Prev Res (Phila); 2012 Apr; 5(4):665-74. PubMed ID: 22318752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
